BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 29695834)

  • 1. Contribution of three-dimensional architecture and tumor-associated fibroblasts to hepcidin regulation in breast cancer.
    Blanchette-Farra N; Kita D; Konstorum A; Tesfay L; Lemler D; Hegde P; Claffey KP; Torti FM; Torti SV
    Oncogene; 2018 Jul; 37(29):4013-4032. PubMed ID: 29695834
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disordered hepcidin-ferroportin signaling promotes breast cancer growth.
    Zhang S; Chen Y; Guo W; Yuan L; Zhang D; Xu Y; Nemeth E; Ganz T; Liu S
    Cell Signal; 2014 Nov; 26(11):2539-50. PubMed ID: 25093806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of hepcidin through GDF-15 in cancer-related anemia.
    Jiang F; Yu WJ; Wang XH; Tang YT; Guo L; Jiao XY
    Clin Chim Acta; 2014 Jan; 428():14-9. PubMed ID: 24384540
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An important role of the hepcidin-ferroportin signaling in affecting tumor growth and metastasis.
    Guo W; Zhang S; Chen Y; Zhang D; Yuan L; Cong H; Liu S
    Acta Biochim Biophys Sin (Shanghai); 2015 Sep; 47(9):703-15. PubMed ID: 26201356
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Podoplanin increases the migration of human fibroblasts and affects the endothelial cell network formation: A possible role for cancer-associated fibroblasts in breast cancer progression.
    Suchanski J; Tejchman A; Zacharski M; Piotrowska A; Grzegrzolka J; Chodaczek G; Nowinska K; Rys J; Dziegiel P; Kieda C; Ugorski M
    PLoS One; 2017; 12(9):e0184970. PubMed ID: 28938000
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of Iron-Related Proteins Differentiate Non-Cancerous and Cancerous Breast Tumors.
    Pizzamiglio S; De Bortoli M; Taverna E; Signore M; Veneroni S; Cho WC; Orlandi R; Verderio P; Bongarzone I
    Int J Mol Sci; 2017 Feb; 18(2):. PubMed ID: 28216608
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor suppressor HIC1 is synergistically compromised by cancer-associated fibroblasts and tumor cells through the IL-6/pSTAT3 axis in breast cancer.
    Sun X; Qu Q; Lao Y; Zhang M; Yin X; Zhu H; Wang Y; Yang J; Yi J; Hao M
    BMC Cancer; 2019 Dec; 19(1):1180. PubMed ID: 31795965
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ferroportin and iron regulation in breast cancer progression and prognosis.
    Pinnix ZK; Miller LD; Wang W; D'Agostino R; Kute T; Willingham MC; Hatcher H; Tesfay L; Sui G; Di X; Torti SV; Torti FM
    Sci Transl Med; 2010 Aug; 2(43):43ra56. PubMed ID: 20686179
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studying hepcidin and related pathways in osteoblasts using a mouse model with insulin receptor substrate 1‑loss of function.
    Liu J; Qian L; Guo L; Feng Y
    Mol Med Rep; 2018 Jan; 17(1):350-357. PubMed ID: 29115497
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CHEK2 represses breast stromal fibroblasts and their paracrine tumor-promoting effects through suppressing SDF-1 and IL-6.
    Al-Rakan MA; Hendrayani SF; Aboussekhra A
    BMC Cancer; 2016 Aug; 16():575. PubMed ID: 27484185
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction with adipocyte stromal cells induces breast cancer malignancy via S100A7 upregulation in breast cancer microenvironment.
    Sakurai M; Miki Y; Takagi K; Suzuki T; Ishida T; Ohuchi N; Sasano H
    Breast Cancer Res; 2017 Jun; 19(1):70. PubMed ID: 28629450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma hepcidin in early-stage breast cancer patients: no relationship with interleukin-6, erythropoietin and erythroferrone.
    Ciniselli CM; De Bortoli M; Taverna E; Varinelli L; Pizzamiglio S; Veneroni S; Bonini C; Orlandi R; Verderio P; Bongarzone I
    Expert Rev Proteomics; 2015; 12(6):695-701. PubMed ID: 26496240
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Effects of Angelica Sinensis Polysaccharide on Tumor Growth and Iron Metabolism by Regulating Hepcidin in Tumor-Bearing Mice.
    Ren F; Li J; Wang Y; Wang Y; Feng S; Yuan Z; Qian X
    Cell Physiol Biochem; 2018; 47(3):1084-1094. PubMed ID: 29843136
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Artemisinin modulating effect on human breast cancer cell lines with different sensitivity to cytostatics.
    Chekhun VF; Lukianova NY; Borikun TV; Zadvorny TV; Mokhir A
    Exp Oncol; 2017 Mar; 39(1):25-29. PubMed ID: 28361857
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Local iron homeostasis in the breast ductal carcinoma microenvironment.
    Marques O; Porto G; Rêma A; Faria F; Cruz Paula A; Gomez-Lazaro M; Silva P; Martins da Silva B; Lopes C
    BMC Cancer; 2016 Mar; 16():187. PubMed ID: 26944411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A potential role for hepcidin in obesity-driven colorectal tumourigenesis.
    Phillips E; Horniblow RD; Poole V; Bedford M; Ward DG; Kirkham AJ; Tomlinson J; Iqbal TH; Tselepis C
    Oncol Rep; 2018 Jan; 39(1):392-400. PubMed ID: 29115635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of Guanosine 5'-diphosphate as Potential Iron Mobilizer: Preventing the Hepcidin-Ferroportin Interaction and Modulating the Interleukin-6/Stat-3 Pathway.
    Angmo S; Tripathi N; Abbat S; Sharma S; Singh SS; Halder A; Yadav K; Shukla G; Sandhir R; Rishi V; Bharatam PV; Yadav H; Singhal NK
    Sci Rep; 2017 Jan; 7():40097. PubMed ID: 28054602
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor necrosis factor alpha and interleukin 11 secreted by malignant breast epithelial cells inhibit adipocyte differentiation by selectively down-regulating CCAAT/enhancer binding protein alpha and peroxisome proliferator-activated receptor gamma: mechanism of desmoplastic reaction.
    Meng L; Zhou J; Sasano H; Suzuki T; Zeitoun KM; Bulun SE
    Cancer Res; 2001 Mar; 61(5):2250-5. PubMed ID: 11280794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stearoyl-CoA desaturase 1 and paracrine diffusible signals have a major role in the promotion of breast cancer cell migration induced by cancer-associated fibroblasts.
    Angelucci C; Maulucci G; Colabianchi A; Iacopino F; D'Alessio A; Maiorana A; Palmieri V; Papi M; De Spirito M; Di Leone A; Masetti R; Sica G
    Br J Cancer; 2015 May; 112(10):1675-86. PubMed ID: 25880005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Clinical Value of Hepcidin in Breast Cancer and Its Bone Metastasis.
    Shao X; Cao F; Tao M
    Ann Clin Lab Sci; 2017 Mar; 47(2):120-128. PubMed ID: 28442512
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.